当前位置: X-MOL 学术Genet. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Disparities in BRCA counseling across providers in a diverse population of young breast cancer survivors.
Genetics in Medicine ( IF 6.6 ) Pub Date : 2020-02-18 , DOI: 10.1038/s41436-020-0762-0
Sonya Reid 1 , Deborah Cragun 2 , Ann Tezak 1 , Anne Weidner 1 , Jaleesa Moore 1 , Ingrid A Mayer 1 , Xiao-Ou Shu 1 , Fei Ye 1 , Run Fan 1 , Susan Vadaparampil 3 , Tuya Pal 1
Affiliation  

PURPOSE All women diagnosed with breast cancer (BC) ≤age 50 should be referred for genetic counseling (GC) and testing. We sought to compare differences in provider practices and access across a racially and ethnically diverse population of young BC survivors. METHODS A registry-based sample of women diagnosed with invasive BC ≤age 50 from 2009 to 2012 was recruited through the Florida Cancer Registry, and completed a questionnaire and medical record release. Differences were compared across those tested with or without the involvement of a board-certified or credentialed genetics health professional (GHP) in (1) clinical and demographic variables and (2) pretest GC elements. RESULTS Of 1622 participants, there were 440 Blacks, 285 Hispanics, and 897 Non-Hispanic Whites. Of 831 participants with medical record verification of testing provider, 170 (20%) had documentation of GHP involvement. Among the 613 who recalled a pretest discussion and had GC elements collected, those with GHP involvement were significantly more likely to recall the seven recognized GC elements. CONCLUSION GHP involvement was associated with adherence to nationally recommended best practices. With the expanding importance of identifying inherited cancers, it is critical to ensure equitable access to best practices across all populations.

中文翻译:

在年轻乳腺癌幸存者的不同人群中,提供者之间的 BRCA 咨询存在差异。

目的所有被诊断患有乳腺癌 (BC) ≤ 50 岁的女性都应转诊进行遗传咨询 (GC) 和检测。我们试图比较不同种族和民族的年轻 BC 幸存者在提供者实践和获取途径方面的差异。方法 从 2009 年到 2012 年,通过佛罗里达州癌症登记处招募了 2009 年至 2012 年被诊断患有侵袭性 BC ≤ 50 岁的基于登记的女性样本,并完成了问卷调查和病历发布。在 (1) 临床和人口统计学变量和 (2) 预测试 GC 元素中,比较了在有或没有委员会认证或认证的遗传学健康专家 (GHP) 参与的情况下测试的差异。结果 在 1622 名参与者中,有 440 名黑人、285 名西班牙裔和 897 名非西班牙裔白人。在 831 名参与者中,有测试提供者的病历验证,170 (20%) 人有 GHP 参与的文件。在回忆起测试前讨论并收集了 GC 元素的 613 人中,那些参与 GHP 的人更有可能回忆起七个公认的 GC 元素。结论 GHP 的参与与遵守国家推荐的最佳实践有关。随着识别遗传性癌症的重要性越来越大,确保所有人群公平获得最佳实践至关重要。
更新日期:2020-02-18
down
wechat
bug